Onyx Stock Falls On Unusually High Volume (ONXX)
NEW YORK (
) --
(Nasdaq:
) is trading at unusually high volume Thursday with 3.5 million shares changing hands. It is currently at 2.2 times its average daily volume and trading down $3.87 (-2.9%) at $129.08 as of 3:36 p.m. ET.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Onyx has a market cap of $9.65 billion and is part of the health care sector and drugs industry. Shares are up 75.7% year to date as of the close of trading on Wednesday.
Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally.
TheStreet Ratings rates
Onyx
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and weak operating cash flow. You can view the full
.
See all heavy volume stocks in our
stocks moving on unusual volume list
or get investment ideas from our
.
.
null